SEC Company Response from TransMedics Group, Inc. (TMDX) (CIK 0001756262) (TMDX) — May 19, 2020
TransMedics Group, Inc. (TMDX) (CIK 0001756262)
Date: May 19, 2020 · CIK: 0001756262 · Accession: 0001193125-20-146178
AI Filing Summary & Sentiment
File numbers found in text: 333-238052
Letter
TRANSMEDICS GROUP, INC.
200 Minuteman Road
Andover, Massachusetts 01810
May 19, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F. Street, N.E.
Washington, D.C. 20549
Attention: Paul Fischer; Mary Beth Breslin
Re: TransMedics Group, Inc. Registration Statement on Form S-3 (File No. 333-238052)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, TransMedics Group, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-238052) (the “Registration Statement”), so that it will be declared effective at 4:30 p.m. Eastern Time on May 21, 2020, or as soon as possible thereafter. The Company hereby authorizes Tara Fisher, counsel to the Company, to orally modify or withdraw this request for acceleration.
It would be appreciated if, as soon as the Registration Statement is declared effective, you would inform Tara Fisher of Ropes & Gray LLP, counsel to the Company, at (617) 235-4824.
Very truly yours,
TRANSMEDICS GROUP, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP TRANSMEDICS GROUP, INC. 200 Minuteman Road Andover, Massachusetts 01810 May 19, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F. Street, N.E. Washington, D.C. 20549 Attention: Paul Fischer; Mary Beth Breslin Re: TransMedics Group, Inc. Registration Statement on Form S-3 (File No. 333-238052) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, TransMedics Group, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-238052) (the “Registration Statement”), so that it will be declared effective at 4:30 p.m. Eastern Time on May 21, 2020, or as soon as possible thereafter. The Company hereby authorizes Tara Fisher, counsel to the Company, to orally modify or withdraw this request for acceleration. It would be appreciated if, as soon as the Registration Statement is declared effective, you would inform Tara Fisher of Ropes & Gray LLP, counsel to the Company, at (617) 235-4824. Very truly yours, TRANSMEDICS GROUP, INC. By: /s/ Stephen Gordon Stephen Gordon Chief Financial Officer, Treasurer and Secretary